Viatris Inc. (NASDAQ: VTRS), a US-based global pharmaceutical company, announced on Monday that it has named Leo Groothuis as a new member of its board of directors.
Groothuis is to fill the vacancy created by the earlier departure of Michael Goettler in April 2023.
Groothuis held the position of general counsel of HAL Investments. He has served as a trusted C-suite and board advisor to certain large companies in both Europe and the United States. He has also held the position of practice leader at NautaDutilh.
Viatris executive chairman Robert J Coury said, 'We are extremely pleased to welcome Leo Groothuis, a recognised top international executive to the Viatris board. We believe his proven strategic, corporate governance and capital markets experience should serve as a tremendous asset for Viatris, as we continue to look for ways to build and unlock value for our shareholders.'
Viatris adds new board director
Bloom Science names new board chair
Prescient Healthcare names new directors
Alcami names new general manager, Biostorage and Pharma Services
Cell Easy Appoints CDMO Expert Dr. Sebastien Ribault as Independent Board Director
Nexus Pharmaceuticals Appoints Two New Board Members
Scorpius BioManufacturing names new vice president, Quality and Regulatory Affairs
NeuroTrauma Sciences names new CMO and EVP of Regulatory Affairs and Quality Assurance